Holger Wesche's most recent trade in Harpoon Therapeutics Inc was a trade of 135,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 28, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Harpoon Therapeutics Inc | Holger Wesche | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 135,000 | 135,000 | - | - | Employee Stock Option (right to buy) | |
| Harpoon Therapeutics Inc | Holger Wesche | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 135,000 | 135,000 | - | - | Employee Stock Option (right to buy) | |
| Harpoon Therapeutics Inc | Holger Wesche | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 01 Jul 2021 | 10,000 | 52,852 (0%) | 0% | 14 | 140,000 | Common Stock |
| Harpoon Therapeutics Inc | Holger Wesche | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 10,000 | 21,002 | - | - | Employee Stock Option (right to buy) | |
| Harpoon Therapeutics Inc | Holger Wesche | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 Jul 2021 | 10,000 | 62,852 (0%) | 0% | 0.6 | 6,000 | Common Stock |
| Harpoon Therapeutics Inc | Holger Wesche | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.41 per share. | 01 Apr 2021 | 9,500 | 53,352 (0%) | 0% | 20.4 | 193,921 | Common Stock |
| Harpoon Therapeutics Inc | Holger Wesche | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 Apr 2021 | 8,466 | 61,318 (0%) | 0% | 0.6 | 5,080 | Common Stock |
| Harpoon Therapeutics Inc | Holger Wesche | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 8,466 | 2,540 | - | - | Employee Stock Option (right to buy) | |
| Harpoon Therapeutics Inc | Holger Wesche | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 Apr 2021 | 1,534 | 62,852 (0%) | 0% | 0.6 | 920 | Common Stock |
| Harpoon Therapeutics Inc | Holger Wesche | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 1,534 | 31,002 | - | - | Employee Stock Option (right to buy) | |
| Harpoon Therapeutics Inc | Holger Wesche | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 21.14 per share. | 01 Apr 2021 | 500 | 52,852 (0%) | 0% | 21.1 | 10,570 | Common Stock |
| Harpoon Therapeutics Inc | Holger Wesche | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 52,000 | 52,000 | - | - | Employee Stock Option (right to buy) | |
| Harpoon Therapeutics Inc | Holger Wesche | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 04 Jan 2021 | 10,000 | 62,852 (0%) | 0% | 0.6 | 6,000 | Common Stock |
| Harpoon Therapeutics Inc | Holger Wesche | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 10,000 | 11,006 | - | - | Employee Stock Option (right to buy) | |
| Harpoon Therapeutics Inc | Holger Wesche | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 19.39 per share. | 04 Jan 2021 | 3,549 | 52,852 (0%) | 0% | 19.4 | 68,828 | Common Stock |
| Harpoon Therapeutics Inc | Holger Wesche | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.30 per share. | 04 Jan 2021 | 3,351 | 56,401 (0%) | 0% | 18.3 | 61,327 | Common Stock |
| Harpoon Therapeutics Inc | Holger Wesche | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 17.32 per share. | 04 Jan 2021 | 3,100 | 59,752 (0%) | 0% | 17.3 | 53,683 | Common Stock |